Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Methylphenidate-induced autoimmune hepatitis.

× No keyword cloud information.

13 in total

1. Autoimmune hepatitis triggered by statins.

Authors: Vamsee Alla; Joseph Abraham; Junaid Siddiqui; Dimple Raina; George Y Wu; Naga P Chalasani; Herbert L Bonkovsky
Journal: J Clin Gastroenterol Date: 2006-09 Impact factor: 3.062

Review 2. Autoimmune hepatitis.

Authors: Edward L Krawitt
Journal: N Engl J Med Date: 2006-01-05 Impact factor: 91.245

3. Methylphenidate in post liver transplant patients.

Authors: L Plutchik; S Snyder; M Drooker; L Chodoff; P Sheiner
Journal: Psychosomatics Date: 1998 Mar-Apr Impact factor: 2.386

4. Hepatotoxicity due to methylphenidate hydrochloride.

Authors: C R Goodman
Journal: N Y State J Med Date: 1972-09-15

Review 5. The pharmacology and toxicology of "ecstasy" (MDMA) and related drugs.

Authors: H Kalant
Journal: CMAJ Date: 2001-10-02 Impact factor: 8.262

Review 6. Extended-release methylphenidate (Ritalin LA).

Authors: Katherine A Lyseng-Williamson; Gillian M Keating
Journal: Drugs Date: 2002 Impact factor: 9.546

Review 7. Review article: mechanisms and management of hepatotoxicity in ecstasy (MDMA) and amphetamine intoxications.

Authors: A L Jones; K J Simpson
Journal: Aliment Pharmacol Ther Date: 1999-02 Impact factor: 8.171

8. Pemoline-induced autoimmune hepatitis.

Authors: M J Sterling; M Kane; N D Grace
Journal: Am J Gastroenterol Date: 1996-10 Impact factor: 10.864

9. Hepatic dysfunction due to intravenous abuse of methylphenidate hydrochloride.

Authors: H Mehta; B Murray; T A LoIudice
Journal: J Clin Gastroenterol Date: 1984-04 Impact factor: 3.062

Review 10. Chemistry, pharmacology, toxicology, and hepatic metabolism of designer drugs of the amphetamine (ecstasy), piperazine, and pyrrolidinophenone types: a synopsis.

Authors: Hans H Maurer; Thomas Kraemer; Dietmar Springer; Roland F Staack
Journal: Ther Drug Monit Date: 2004-04 Impact factor: 3.681

4 in total

Review 1. Methylphenidate for the treatment of depressive symptoms, including fatigue and apathy, in medically ill older adults and terminally ill adults.

Authors: Susan E Hardy
Journal: Am J Geriatr Pharmacother Date: 2009-02

2. Hepato-Protection Effect of Curcumin Against Methylphenidate-Induced Hepatotoxicity: Histological and Biochemical Evidences.

Authors: Haleh Ahmadinasab; Majid Motaghinejad; Bahareh Arabzadeh Nosratabad; Seyedehnahal Bozorgniahosseini; Parastoo Rostami; Golbarg Shabani Jafarabadi; Manijeh Motevalian
Journal: Int J Prev Med Date: 2022-04-08

Review 3. Drug-induced autoimmune-like hepatitis.

Authors: Albert J Czaja
Journal: Dig Dis Sci Date: 2011-02-16 Impact factor: 3.487

4. Liver Transplant in a Patient under Methylphenidate Therapy: A Case Report and Review of the Literature.

Authors: Hoi Y Tong; Carmen Díaz; Elena Collantes; Nicolás Medrano; Alberto M Borobia; Paloma Jara; Elena Ramírez
Journal: Case Rep Pediatr Date: 2015-01-22

4 in total